TY  - RPRT
TI  - MAPK Pathway Inhibition as A Rational Therapeutic Strategy for MiR-138-5p/PAQR3 Dysregulation-mediated Epirubicin Resistance in Triple-negative Breast Cancer
AU  - Huang, J.
AU  - Xiao, Y.
AU  - Zeng, S.
AU  - Wang, X.
AU  - Li, H.
AU  - Xiang, T.
AU  - Kong, L.
AU  - Ren, G.
PY  - 2021
DO  - 10.1101/2021.02.28.433242
UR  - https://www.biorxiv.org/content/10.1101/2021.02.28.433242v1
ID  - 10.1101/2021.02.28.433242
ER  -